Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Q3 2024 Earnings Conference Call November 7, 2024 8:30 AM ET
Company Participants
Richard Daly – President and Chief Executive Officer
Michael Kalb – Chief Financial Officer
Jeffrey Del Carmen – Chief Commercial Officer
Steven Miller – Chief Operating Officer and Chief Scientific Officer
Gary Ingenito – Chief Medical & Regulatory Officer
Conference Call Participants
Joon Lee – Truist Securities
Charles Duncan – Cantor Fitzgerald
Samantha Semenkow – Citi Investment Research
Operator
Thank you for standing by. My name is Kris and I will be your conference operator today. At this time, I would like to welcome everyone to the Catalyst Pharmaceuticals’ Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] Thank you.
I would now like to turn the call over to Mike Kalb, CFO. Please go ahead.
Michael Kalb
Thank you. Good morning, everyone, and thank you for joining our conference call to discuss Catalyst Pharmaceuticals’ third quarter 2024 financial results and business highlights. Rich Daly, President and CEO will lead the call today; and Jeffrey Del Carmen, our Chief Commercial Officer, and I will also present. Additionally, Dr. Steve Miller, our Chief Operating Officer and Chief Scientific Officer will be available for the Q&A.
Before we begin, I would like to remind you that in our remarks this morning and in the Q&A session, we will make statements about expected future results, which may be forward-looking statements for purposes of federal securities laws. These statements relate to our current expectations, estimates, and projections, and are not guarantees of future performance. They involve risks, uncertainties, and assumptions that are difficult to predict and may not prove to be accurate. Actual results may vary from the expectations contained in our forward-looking statements.
These forward-looking statements should be considered only in conjunction with the detailed information
